DDInter1255 DDInter1396
Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal receptor blockers have higher selectivity and offer better rates of adverse effects. Nadolol was granted FDA approval on 10 December 1979.
An oligosaccharide antibiotic produced by various streptomyces. [PubChem]
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Kanamycin
Kanamycin {u} (Compound) resembles {v} (Compound) Paromomycin
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Neomycin
Neomycin {u} (Compound) resembles {v} (Compound) Paromomycin
Nadolol {u} (Compound) causes {v} (Side Effect) Diarrhoea
Diarrhoea {u} (Side Effect) is caused by {v} (Compound) Paromomycin
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Kanamycin
Kanamycin {u} (Compound) resembles {v} (Compound) Tobramycin
Tobramycin {u} (Compound) resembles {v} (Compound) Paromomycin
Nadolol {u} (Compound) causes {v} (Side Effect) Diarrhoea
Diarrhoea {u} (Side Effect) is caused by {v} (Compound) Tobramycin
Tobramycin {u} (Compound) resembles {v} (Compound) Paromomycin
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Kanamycin
Kanamycin {u} (Compound) resembles {v} (Compound) Amikacin
Amikacin {u} (Compound) resembles {v} (Compound) Paromomycin
Nadolol {u} (Compound) causes {v} (Side Effect) Pain
Pain {u} (Side Effect) is caused by {v} (Compound) Kanamycin
Kanamycin {u} (Compound) resembles {v} (Compound) Paromomycin
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Neomycin
Neomycin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Lactulose
Lactulose {u} (Compound) resembles {v} (Compound) Paromomycin
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Kanamycin
Kanamycin {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Neomycin
Neomycin {u} (Compound) resembles {v} (Compound) Paromomycin
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Neomycin
Neomycin {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Kanamycin
Kanamycin {u} (Compound) resembles {v} (Compound) Paromomycin
Nadolol may cause a minor interaction that can limit clinical effects when taken with Kanamycin and Kanamycin (Compound) resembles Paromomycin (Compound)
Nadolol may cause a minor interaction that can limit clinical effects when taken with Neomycin and Neomycin (Compound) resembles Paromomycin (Compound)
Nadolol (Compound) causes Diarrhoea (Side Effect) and Diarrhoea (Side Effect) is caused by Paromomycin (Compound)
Nadolol may cause a minor interaction that can limit clinical effects when taken with Kanamycin and Kanamycin (Compound) resembles Tobramycin (Compound) and Tobramycin (Compound) resembles Paromomycin (Compound)
Nadolol (Compound) causes Diarrhoea (Side Effect) and Diarrhoea (Side Effect) is caused by Tobramycin (Compound) and Tobramycin (Compound) resembles Paromomycin (Compound)
Nadolol may cause a minor interaction that can limit clinical effects when taken with Kanamycin and Kanamycin (Compound) resembles Amikacin (Compound) and Amikacin (Compound) resembles Paromomycin (Compound)
Nadolol (Compound) causes Pain (Side Effect) and Pain (Side Effect) is caused by Kanamycin (Compound) and Kanamycin (Compound) resembles Paromomycin (Compound)
Nadolol may cause a minor interaction that can limit clinical effects when taken with Neomycin and Neomycin may cause a minor interaction that can limit clinical effects when taken with Lactulose and Lactulose (Compound) resembles Paromomycin (Compound)
Nadolol may cause a minor interaction that can limit clinical effects when taken with Kanamycin and Kanamycin (Compound) resembles Neomycin (Compound) and Kanamycin may cause a moderate interaction that could exacerbate diseases when taken with Neomycin and Neomycin (Compound) resembles Paromomycin (Compound)
Nadolol may cause a minor interaction that can limit clinical effects when taken with Neomycin and Neomycin (Compound) resembles Kanamycin (Compound) and Neomycin may cause a moderate interaction that could exacerbate diseases when taken with Kanamycin and Kanamycin (Compound) resembles Paromomycin (Compound)